We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

960 hedge funds and large institutions have $45.5B invested in Thermo Fisher Scientific in 2014 Q4 according to their latest regulatory filings, with 111 funds opening new positions, 346 increasing their positions, 368 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 111 | Existing positions closed: 58

36% more call options, than puts

Call options by funds: $195M | Put options by funds: $143M

5% more funds holding

Funds holding: 917960 (+43)

3% more capital invested

Capital invested by funds: $44.1B → $45.5B (+$1.41B)

0% more funds holding in top 10

Funds holding in top 10: 6767 (0)

0% less ownership

Funds ownership: 90.96%90.96% (-0%)

6% less repeat investments, than reductions

Existing positions increased: 346 | Existing positions reduced: 368

Holders
960
Holders Change
+43
Holders Change %
+4.69%
% of All Funds
25.6%
Holding in Top 10
67
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
1.79%
New
111
Increased
346
Reduced
368
Closed
58
Calls
$195M
Puts
$143M
Net Calls
+$51.9M
Net Calls Change
-$22.1M
Name Holding Trade Value Shares
Change
Change in
Stake
AIA
251
Avalon Investment & Advisory
Texas
$13.7M +$1.23M +10,103 +10%
ASA
252
Armstrong Shaw Associates
Connecticut
$13.7M -$468K -3,851 -3%
State of New Jersey Common Pension Fund D
253
State of New Jersey Common Pension Fund D
New Jersey
$13.7M
DMIC
254
Dixon Mitchell Investment Counsel
British Columbia, Canada
$13.3M
AC
255
Addenda Capital
Quebec, Canada
$13.1M +$1.99M +16,393 +17%
CCMH
256
Cornerstone Capital Management Holdings
New York
$13M +$375K +3,085 +3%
HIMCH
257
Hartford Investment Management Co (HIMCO)
Connecticut
$12.9M -$210K -1,731 -2%
SCM
258
Suffolk Capital Management
New York
$12.9M -$76K -625 -0.6%
HCM
259
Howland Capital Management
Massachusetts
$12.9M -$396K -3,255 -3%
QIM
260
Quest Investment Management
Oregon
$12.8M -$1.48M -12,155 -11%
PAM
261
Panagora Asset Management
Massachusetts
$12.5M -$9.23M -75,934 -43%
IRF
262
IBM Retirement Fund
New York
$12.3M -$56.4K -464 -0.5%
Citigroup
263
Citigroup
New York
$12.2M -$2.02M -16,578 -15%
GL
264
GLG LLC
New York
$12.1M +$1.86M +15,303 +19%
AIM
265
Artemis Investment Management
United Kingdom
$12.1M +$506K +4,163 +5%
BPB
266
Badgley, Phelps & Bell
Washington
$12M -$267K -2,194 -2%
TAM
267
Taurus Asset Management
New York
$12M -$49.6K -408 -0.4%
FAF
268
Fjarde Ap-fonden
Sweden
$11.9M -$710K -5,837 -6%
EIM
269
ExxonMobil Investment Management
Texas
$11.8M -$419K -3,448 -4%
UB
270
UMB Bank
Missouri
$11.8M -$159K -1,310 -1%
SMDAM
271
Sumitomo Mitsui DS Asset Management
Japan
$11.7M -$776K -6,379 -6%
YIA
272
YHB Investment Advisors
Connecticut
$11.6M +$326K +2,683 +3%
AIMCA
273
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$11.6M +$2.49M +20,500 +29%
SAM
274
Shell Asset Management
Netherlands
$11.5M +$1.29M +10,637 +13%
JPMIA
275
J.P. Marvel Investment Advisors
Massachusetts
$11.5M -$607K -4,990 -5%

TMO Hedge Fund Activity: Q4 2014 in Review

960 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2014, worth a combined $45.5B — up 3.2% from $44.1B a quarter earlier.

Buyers outnumbered sellers: 111 funds opened new TMO positions and 58 closed out — a net gain of 53 holders — while 346 added to existing stakes and 368 trimmed.

The largest buyer was Capital World Investors, adding an estimated $393M. The largest seller was Viking Global Investors, cutting an estimated $266M.

  • 960 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2014, up from 917 in Q3 2014.
  • Funds reported $45.5B of Thermo Fisher Scientific stock for Q4 2014, up 3.2% quarter-over-quarter.
  • 111 funds opened new Thermo Fisher Scientific positions in Q4 2014 and 58 closed out, a net change of +53 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2014 was Capital World Investors, an estimated $393M added.
  • The largest Thermo Fisher Scientific seller in Q4 2014 was Viking Global Investors, an estimated $266M sold.

Based on aggregated 13F filings for Q4 2014.